{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:45:15Z","timestamp":1761709515341,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T00:00:00Z","timestamp":1534550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Development Program","award":["2016YFC0905000"],"award-info":[{"award-number":["2016YFC0905000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81522048, 81573511"],"award-info":[{"award-number":["81522048, 81573511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Driven Project of Central South University","award":["2016CX024"],"award-info":[{"award-number":["2016CX024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12020-018-1715-0","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T07:06:55Z","timestamp":1534576015000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study"],"prefix":"10.1007","volume":"63","author":[{"given":"Bao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazhong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiecan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,18]]},"reference":[{"key":"1715_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 8 edn. \n                    http:\/\/www.diabetesatlas.org\n                    \n                   (2017). Accessed 2017."},{"issue":"24","key":"1715_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1001\/jama.2017.7596","volume":"317","author":"L Wang","year":"2017","unstructured":"L. Wang, P. Gao, M. Zhang, Z. Huang, D. Zhang, Q. Deng, Y. Li, Z. Zhao, X. Qin, D. Jin, M. Zhou, X. Tang, Y. Hu, L. Wang, Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317(24), 2515\u20132523 (2017). \n                    https:\/\/doi.org\/10.1001\/jama.2017.7596","journal-title":"JAMA"},{"issue":"4","key":"1715_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, M. Laakso, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Eng. J. Med. 339(4), 229\u2013234 (1998). \n                    https:\/\/doi.org\/10.1056\/nejm199807233390404","journal-title":"N. Eng. J. Med."},{"issue":"8","key":"1715_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/diacare.24.8.1397","volume":"24","author":"SH Saydah","year":"2001","unstructured":"S.H. Saydah, M. Miret, J. Sung, C. Varas, D. Gause, F.L. Brancati, Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24(8), 1397\u20131402 (2001)","journal-title":"Diabetes Care"},{"issue":"9131","key":"1715_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","year":"1998","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)., UK Prospective Diabetes Study (UKPDS) Group. Lancet (Lond., Engl.) 352(9131), 837\u2013853 (1998)","journal-title":"Lancet (Lond., Engl.)"},{"issue":"14","key":"1715_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"D.M. Nathan, S. Genuth, J. Lachin, P. Cleary, O. Crofford, M. Davis, L. Rand, C. Siebert, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329(14), 977\u2013986 (1993). \n                    https:\/\/doi.org\/10.1056\/nejm199309303291401","journal-title":"N. Eng. J. Med."},{"issue":"suppl 2","key":"1715_CR7","first-page":"B21","volume":"23","author":"M Shichiri","year":"2000","unstructured":"M. Shichiri, H. Kishikawa, Y. Ohkubo, N. Wake, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23(suppl 2), B21\u2013B29 (2000)","journal-title":"Diabetes Care"},{"issue":"2","key":"1715_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/archinte.1997.00440230053007","volume":"157","author":"C Abraira","year":"1997","unstructured":"C. Abraira, J. Colwell, F. Nuttall, C.T. Sawin, W. Henderson, J.P. Comstock, N.V. Emanuele, S.R. Levin, I. Pacold, H.S. Lee, Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch. Intern. Med. 157(2), 181\u2013188 (1997)","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"1715_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ahj.2005.09.015","volume":"152","author":"C Stettler","year":"2006","unstructured":"C. Stettler, S. Allemann, P. Juni, C.A. Cull, R.R. Holman, M. Egger, S. Krahenbuhl, P. Diem, Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am. Heart J. 152(1), 27\u201338 (2006). \n                    https:\/\/doi.org\/10.1016\/j.ahj.2005.09.015","journal-title":"Am. Heart J."},{"issue":"9713","key":"1715_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","volume":"375","author":"CJ Currie","year":"2010","unstructured":"C.J. Currie, J.R. Peters, A. Tynan, M. Evans, R.J. Heine, O.L. Bracco, T. Zagar, C.D. Poole, Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (Lond., Engl.) 375(9713), 481\u2013489 (2010). \n                    https:\/\/doi.org\/10.1016\/s0140-6736(09)61969-3","journal-title":"Lancet (Lond., Engl.)"},{"issue":"3","key":"1715_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2337\/diacare.21.3.360","volume":"21","author":"B Balkau","year":"1998","unstructured":"B. Balkau, M. Shipley, R.J. Jarrett, K. Pyorala, M. Pyorala, A. Forhan, E. Eschwege, High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21(3), 360\u2013367 (1998)","journal-title":"Diabetes Care"},{"issue":"2","key":"1715_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2337\/diacare.22.2.233","volume":"22","author":"M Coutinho","year":"1999","unstructured":"M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf, The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22(2), 233\u2013240 (1999)","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"1715_CR13","first-page":"S106","volume":"26","author":"DE Goldstein","year":"2003","unstructured":"D.E. Goldstein, R.R. Little, R.A. Lorenz, J.I. Malone, D.M. Nathan, C.M. Peterson, Tests of glycemia in diabetes. Diabetes Care 26(Suppl 1), S106\u2013S108 (2003)","journal-title":"Diabetes Care"},{"issue":"9","key":"1715_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0908359","volume":"362","author":"E Selvin","year":"2010","unstructured":"E. Selvin, M.W. Steffes, H. Zhu, K. Matsushita, L. Wagenknecht, J. Pankow, J. Coresh, F.L. Brancati, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Eng. J. Med. 362(9), 800\u2013811 (2010). \n                    https:\/\/doi.org\/10.1056\/NEJMoa0908359","journal-title":"N. Eng. J. Med."},{"issue":"6","key":"1715_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","volume":"141","author":"E Selvin","year":"2004","unstructured":"E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, N.R. Powe, S.H. Golden, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141(6), 421\u2013431 (2004)","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"1715_CR16","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/archinte.1994.00420210113013","volume":"154","author":"SE Moss","year":"1994","unstructured":"S.E. Moss, R. Klein, B.E. Klein, S.M. Meuer, The association of glycemia and cause-specific mortality in a diabetic population. Arch. Intern. Med. 154(21), 2473\u20132479 (1994)","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"1715_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40618-015-0389-1","volume":"39","author":"X Guan","year":"2016","unstructured":"X. Guan, L. Zheng, G. Sun, X. Guo, Y. Li, H. Song, F. Tian, Y. Sun, The changing relationship between HbA1c and FPG according to different FPG ranges. J. Endocrinol. Invest. 39(5), 523\u2013528 (2016). \n                    https:\/\/doi.org\/10.1007\/s40618-015-0389-1","journal-title":"J. Endocrinol. Invest."},{"issue":"24","key":"1715_CR18","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, M. Marre, M. Cooper, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, S. Heller, L. Liu, G. Mancia, C.E. Mogensen, C. Pan, N. Poulter, A. Rodgers, B. Williams, S. Bompoint, B.E. de Galan, R. Joshi, F. Travert, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Eng. J. Med. 358(24), 2560\u20132572 (2008). \n                    https:\/\/doi.org\/10.1056\/NEJMoa0802987","journal-title":"N. Eng. J. Med."},{"issue":"15","key":"1715_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","volume":"371","author":"S Zoungas","year":"2014","unstructured":"S. Zoungas, J. Chalmers, B. Neal, L. Billot, Q. Li, Y. Hirakawa, H. Arima, H. Monaghan, R. Joshi, S. Colagiuri, M.E. Cooper, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, S. Heller, L. Lisheng, G. Mancia, M. Marre, D.R. Matthews, C.E. Mogensen, V. Perkovic, N. Poulter, A. Rodgers, B. Williams, S. MacMahon, A. Patel, M. Woodward, Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N. Eng. J. Med. 371(15), 1392\u20131406 (2014). \n                    https:\/\/doi.org\/10.1056\/NEJMoa1407963","journal-title":"N. Eng. J. Med."},{"issue":"4","key":"1715_CR20","first-page":"S21","volume":"19","author":"Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus.","year":"2001","unstructured":"Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus., Action in diabetes and vascular disease: PreterAx and diamicron modified-release controlled evaluation. J. Hypertens. Suppl.: Off. J. Int. Soc. Hypertens. 19(4), S21\u2013S28 (2001)","journal-title":"J. Hypertens. Suppl.: Off. J. Int. Soc. Hypertens."},{"key":"1715_CR21","doi-asserted-by":"crossref","unstructured":"ADVANCE Management Committee. Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation. Diabetologia 44(9), 1118\u20131120 (2001).","DOI":"10.1007\/s001250100612"},{"key":"1715_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ebiom.2016.10.025","volume":"13","author":"F He","year":"2016","unstructured":"F. He, M. Liu, Z. Chen, G. Liu, Z. Wang, R. Liu, J. Luo, J. Tang, X. Wang, X. Liu, H. Zhou, X. Chen, Z. Liu, W. Zhang, Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment. EBioMedicine 13, 181\u2013189 (2016). \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.025","journal-title":"EBioMedicine"},{"key":"1715_CR23","unstructured":"I.M. Stratton, A.I. Adler, H.A.Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (Clinical research ed.) 321(7258), 405\u2013412 (2000)"},{"issue":"2","key":"1715_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdiacomp.2005.06.013","volume":"20","author":"MS Kirkman","year":"2006","unstructured":"M.S. Kirkman, M. McCarren, J. Shah, W. Duckworth, C. Abraira, The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes. J. Diabetes Complicat. 20(2), 75\u201380 (2006). \n                    https:\/\/doi.org\/10.1016\/j.jdiacomp.2005.06.013","journal-title":"J. Diabetes Complicat."},{"issue":"24","key":"1715_CR25","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, J.B. Buse, W.C. Cushman, S. Genuth, F. Ismail-Beigi, R.H. Grimm Jr., J.L. Probstfield, D.G. Simons-Morton, W.T. Friedewald, Effects of intensive glucose lowering in type 2 diabetes. N. Eng. J. Med. 358(24), 2545\u20132559 (2008). \n                    https:\/\/doi.org\/10.1056\/NEJMoa0802743","journal-title":"N. Eng. J. Med."},{"issue":"6","key":"1715_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1056-8727(02)00277-5","volume":"17","author":"C Abraira","year":"2003","unstructured":"C. Abraira, W. Duckworth, M. McCarren, N. Emanuele, D. Arca, D. Reda, W. Henderson, Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J. Diabetes Complicat. 17(6), 314\u2013322 (2003)","journal-title":"J. Diabetes Complicat."},{"issue":"7","key":"1715_CR27","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2337\/db14-0059","volume":"63","author":"PE Cryer","year":"2014","unstructured":"P.E. Cryer, Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63(7), 2188\u20132195 (2014). \n                    https:\/\/doi.org\/10.2337\/db14-0059","journal-title":"Diabetes"},{"issue":"1","key":"1715_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A.L. Peters, A. Tsapas, R. Wender, D.R. Matthews, Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38(1), 140\u2013149 (2015). \n                    https:\/\/doi.org\/10.2337\/dc14-2441","journal-title":"Diabetes Care"},{"issue":"10","key":"1715_CR29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2016.0299","volume":"315","author":"KJ Lipska","year":"2016","unstructured":"K.J. Lipska, H. Krumholz, T. Soones, S.J. Lee, Polypharmacy in the aging patient: A review of glycemic control in older adults with type 2 diabetes. JAMA 315(10), 1034\u20131045 (2016). \n                    https:\/\/doi.org\/10.1001\/jama.2016.0299","journal-title":"JAMA"},{"issue":"1","key":"1715_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00125-017-4421-1","volume":"61","author":"MK Rutter","year":"2018","unstructured":"M.K. Rutter, Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes. Diabetologia 61(1), 43\u201347 (2018). \n                    https:\/\/doi.org\/10.1007\/s00125-017-4421-1","journal-title":"Diabetologia"},{"issue":"1","key":"1715_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","volume":"61","author":"B Zinman","year":"2018","unstructured":"B. Zinman, S.P. Marso, N.R. Poulter, S.S. Emerson, T.R. Pieber, R.E. Pratley, M. Lange, K. Brown-Frandsen, A. Moses, A.M. Ocampo Francisco, J. Barner Lekdorf, K. Kvist, J.B. Buse, Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia 61(1), 48\u201357 (2018). \n                    https:\/\/doi.org\/10.1007\/s00125-017-4423-z","journal-title":"Diabetologia"},{"issue":"1","key":"1715_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"C.R.L. Cardoso, N.C. Leite, C.B.M. Moram, G.F. Salles, Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2. Diabetes Cohort Study 17(1), 33 (2018). \n                    https:\/\/doi.org\/10.1186\/s12933-018-0677-0","journal-title":"Diabetes Cohort Study"},{"issue":"9958","key":"1715_CR33","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/S0140-6736(14)60611-5","volume":"384","author":"HC Gerstein","year":"2014","unstructured":"H.C. Gerstein, M.E. Miller, F. Ismail-Beigi, J. Largay, C. McDonald, H.A. Lochnan, G.L. Booth, Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 384(9958), 1936\u20131941 (2014). \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)60611-5","journal-title":"Lancet"},{"issue":"22","key":"1715_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"B. Zinman, C. Wanner, J.M. Lachin, D. Fitchett, E. Bluhmki, S. Hantel, M. Mattheus, T. Devins, O.E. Johansen, H.J. Woerle, U.C. Broedl, S.E. Inzucchi, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Eng. J. Med. 373(22), 2117\u20132128 (2015). \n                    https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N. Eng. J. Med."},{"issue":"19","key":"1715_CR35","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"S.P. Marso, S.C. Bain, A. Consoli, F.G. Eliaschewitz, E. J\u00f3dar, L.A. Leiter, I. Lingvay, J. Rosenstock, J. Seufert, M.L. Warren, V. Woo, O. Hansen, A.G. Holst, J. Pettersson, T. Vilsb\u00f8ll, Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Eng. J. Med. 375(19), 1834\u20131844 (2016). \n                    https:\/\/doi.org\/10.1056\/NEJMoa1607141","journal-title":"N. Eng. J. Med."},{"issue":"4","key":"1715_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"S.P. Marso, G.H. Daniels, K. Brown-Frandsen, P. Kristensen, J.F. Mann, M.A. Nauck, S.E. Nissen, S. Pocock, N.R. Poulter, L.S. Ravn, W.M. Steinberg, M. Stockner, B. Zinman, R.M. Bergenstal, J.B. Buse, Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Eng. J. Med. 375(4), 311\u2013322 (2016). \n                    https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N. Eng. J. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1715-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T20:45:24Z","timestamp":1569098724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1715-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1715-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2018,8,18]]},"assertion":[{"value":"15 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee and was in accordance with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provide written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}